Submit Deal

Announced

31 Jul 2025

Completed

24 Sep 2025

Advantage Partners and LYFE Capital completed the acquisition of 72.80% stake in Nihon Chouzai for JPY100bn.

Synopsis

Advantage Partners, a private equity investment firm in Japan, and LYFE Capital, a healthcare-focused private equity company, completed the acquisition of 72.80%% stake in Nihon Chouzai, a pharmaceutical company that offers medical insurance, online medicine, and health consultation services, for JPY100bn.

Principals

target

Nihon Chouzai

bidder

Lyfe Capital

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

Market Context

Sort

Seller Team (2)

kazunori ogi

President and CEO at NIHON CHOUZAI

Manager

target

Deal

£ 505 M

Total Value

takuya sakurai

Executive Officer, General Manager of Group Corporate Planning Department at NIHON CHOUZAI

Manager

target

Deal

£ 505 M

Total Value

Bidder Team (4)

james zhao

Founder at LYFE CAPITAL

Investor

bidder

Deal

£ 505 M

Total Value

richard folsom

Co-Founder and Representative Partner at ADVANTAGE PARTNERS LLP

Investor

bidder

Deals

£ 789 M

Total Value

atushi komatsuzaki

Managing Director at DC Advisory

Financial Advisor

bidder

Deals

£ 1.91 B

Total Value

masashi kubota

Managing Director at DC Advisory

Financial Advisor

bidder

Deals

£ 1.32 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy